DENA
NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
13/08/2026
Voltar para busca
Dado oficial do USPTO
AKREDERO
Essa marca aparece no histórico oficial do USPTO.
Mesmo quando o status está encerrado, o histórico ajuda a calibrar o risco, evitar repetição de erros e definir uma estratégia segura de naming.
NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILEDTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Tipo de processo
Pedido e registro
Eventos registrados
34
Atualização mais recente
13/08/2026
Classificação
Inactive
Tipo de marca
Verbal
Classes Nice
5
Data de depósito
13/09/2019
Data de registro
05/01/2021
Data de expiração
-
Ação recomendada
Use este histórico como insumo para naming, mas confirme disponibilidade atual em todas as classes relevantes.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
21/01/2026
Última transação
13/08/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
404
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
25
Localização do titular
CH
Examinador
DYER, ERIN ZASKODA
Unidade examinadora
L30
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
NOVARTIS AG
Representantes
Maury M. Tepper, III Tepper & Eyster, PLLC
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune systemthe metabolic systemthe endocrine systemthe musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
Publicações
Histórico de despachos e eventos da marca no USPTO.
34 publicações encontradas
DETH
DEATH OF INTERNATIONAL REGISTRATION
13/08/2026
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
05/01/2026
FINV
FINAL DECISION TRANSACTION PROCESSED BY IB
02/05/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
10/04/2021
FIMP
FINAL DISPOSITION PROCESSED
10/04/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
05/04/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
05/01/2021
GPNX
NOTIFICATION PROCESSED BY IB
24/10/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
20/10/2020
PUBO
PUBLISHED FOR OPPOSITION
20/10/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
30/09/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
30/09/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
30/09/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
14/09/2020
RFNT
REFUSAL PROCESSED BY IB
06/03/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
20/02/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
20/02/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
20/02/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
20/02/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/02/2020
RFRR
REFUSAL PROCESSED BY MPU
08/02/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
17/01/2020
CNRT
NON-FINAL ACTION WRITTEN
16/01/2020
RFWR
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
14/01/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
20/12/2019
CNRT
NON-FINAL ACTION WRITTEN
19/12/2019
DOCK
ASSIGNED TO EXAMINER
13/12/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/12/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/12/2019
MAFR
APPLICATION FILING RECEIPT MAILED
19/11/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
14/11/2019
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
12/11/2019
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
07/11/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace AKREDERO ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.